Treatment of skin disorders with short chain fatty acids
AssigneeTemple University of the Commonwealth System of Higher Education
InventorsAlla Arzumanyan, Ira Spector, Mark A. Feitelson
Life of this patent
Estimating the term…
Abstract
The present disclosure describes methods of treating a condition comprising administering a pharmaceutical composition comprising at least one short chain fatty acid (SCFA). The disclosed methods can be used to treat a skin disorder or an autoimmune disorder.
Claims29
A method of treating a condition, the method comprising:
- a. administering a first pharmaceutical composition to a subject in need thereof, wherein the first pharmaceutical composition comprises a therapeutically-effective amount of a compound that is a short chain fatty acid or a pharmaceutically-acceptable salt thereof;
- and
- b. administering a second pharmaceutical composition to the subject, wherein the second pharmaceutical composition comprises a therapeutically-effective amount of a phosphodiesterase-4 (PDE4) inhibitor.
A method of treating a condition, the method comprising administering to a subject in need thereof a therapeutically-effective amount of a first pharmaceutical composition comprising at least one SCFA and a reduced amount of a second therapy, wherein the reduced amount of the second therapy is therapeutically effective for treating the condition in combination with the therapeutically-effective amount of the first pharmaceutical composition comprising at least one SCFA, and wherein the reduced amount of the second therapy is less than an amount of the second therapy that is therapeutically effective for the condition in absence of the therapeutically-effective amount of the first pharmaceutical composition comprising at least one SCFA.
Dependencies are inferred from the claim text.